Showing results (81-90 of 117) with videos related to
Sort By:
Pageof 12
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanomaP R Dunbar, J L Chen, D Chao, et al.Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|June 16, 2009
Incidence of complications in bronchoscopy. Multicentre prospective study of 20,986 bronchoscopiesN Facciolongo, M Patelli, S Gasparini, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogueD Valmori, F Lévy, I Miconnet, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patientsD Valmori, V Dutoit, D Liénard, et al.European Journal of Immunology|June 26, 1999
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patientsD E Speiser, D Valmori, D Rimoldi, et al.Cancer Research|August 27, 1999
Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376D Valmori, M J Pittet, C Vonarbourg, et al.The Annals of Thoracic Surgery|February 1, 1991
Chest wall involvement by lung cancer: computed tomographic detection and results of operationG B Ratto, G Piacenza, C Frola, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptaseA K Sewell, D A Price, H Teisserenc, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 8, 1998
Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I moleculesM Colonna, J Samaridis, M Cella, et al.Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responsesP André, M Groettrup, P Klenerman, et al.Pageof 12